NEW YORK, Oct. 28 (GenomeWeb News) - Novartis' Institutes for BioMedical Research and the Broad Institute have partnered to look for genetic causes of type 2 diabetes, the groups said today.
The collaboration, called the Broad-Novartis Diabetes Initiative, will bring together physicians, geneticists, computational scientists, pharmaceutical researchers, and others to identify genetic risk factors for developing the disease and its complications.
Researchers will study thousands of DNA samples provided by Leif Groop, a professor of endocrinology at